Table 2.
Outcome value | Pemetrexed (N = 441) |
Placebo (N = 222) |
P value |
---|---|---|---|
Response rate (% of patients) | 6.8 | 1.8 | 0.05 |
Median overall survival (months) | 13.4 | 10.6 | 0.012 |
Median progression free survival (months) | 4.3 | 2.6 | <0.0001 |
Outcome value | Pemetrexed (N = 441) |
Placebo (N = 222) |
P value |
---|---|---|---|
Response rate (% of patients) | 6.8 | 1.8 | 0.05 |
Median overall survival (months) | 13.4 | 10.6 | 0.012 |
Median progression free survival (months) | 4.3 | 2.6 | <0.0001 |